Exports In 2023, Sweden exported $5.94B in Vaccines, blood, antisera, toxins and cultures, making it the 15th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 4th most exported product in Sweden. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Sweden are: United States ($2.41B), Germany ($955M), France ($426M), Austria ($384M), and China ($347M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Sweden between 2022 and 2023 were United States ($1.16B), Russia ($163M), and South Korea ($149M).
Imports In 2023, Sweden imported $2.78B in Vaccines, blood, antisera, toxins and cultures, becoming the 20th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in Sweden. Sweden imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($784M), United States ($737M), Belgium ($297M), Netherlands ($251M), and Ireland ($121M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Sweden between 2022 and 2023 were Germany ($158M), Ireland ($83.5M), and South Korea ($30.2M).